Clinical Trials in Dallas

Showing 4221-4240 of 17,468 trials

SLC13A5 Deficiency Natural History Study - United States Only

NCT06144957

SLC13A5 deficiency (Citrate Transporter Disorder, EIEE 25) is a rare genetic disorder with neurodevelopmental delays and seizure onset in the first few days of life. This natural history study is designed to address the lack of understanding of disease progression. Additionally it will identify clinical and biomarker endpoints for use in future clinical trials.

Citrate Transporter DeficiencyEpilepsyRare Diseases+7 more

TESS Research Foundation17 participantsStarted Dec 2021

Palo Alto, California, United States • Providence, Rhode Island, United States • Dallas, Texas, United States

TERMINATEDPhase 3< 1 mile

OPT-302 With Aflibercept in Neovascular Age-related Macular Degeneration (nAMD)

NCT04757636

A 2-year phase 3, multicentre, randomised, parallel-group, sham-controlled, double-masked study. Primary efficacy will be determined at Week 52.

Neovascular Age-related Macular Degeneration

Opthea Limited998 participantsStarted Mar 2021

Phoenix, Arizona, United States • Arcadia, California, United States • Huntington Beach, California, United States +206 more locations

SLC13A5 Deficiency Natural History Study - United States Only

OPT-302 With Aflibercept in Neovascular Age-related Macular Degeneration (nAMD)

Find Trials by Condition in Dallas

A Maintenance and Long-Term Extension Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Participants With Crohn's Disease Who Completed the Studies M14-431 or M14-433

A Study of INCB099280 in Combination With Adagrasib in Adults With Advanced Solid Tumors Harboring a KRASG12C Mutation

A Study to Compare the Efficacy and Safety of JCAR017 to Standard of Care in Adult Subjects With High-risk, Transplant-eligible Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphomas

Connect® MM- The Multiple Myeloma Disease Registry

A Phase 3 Study to Evaluate Safety and Biomarkers of Resmetirom (MGL-3196) in Patients With Non-alcoholic Fatty Liver Disease (NAFLD), MAESTRO-NAFLD-Open-Label-Extension (MAESTRO-NAFLD-OLE)

A Study of TRK-950 When Used in Combination With Ramucirumab and Paclitaxel in Patients With Gastric Cancer

A Comparison of PT027 vs PT007 Used as Needed in Participants With Asthma

Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening

SAR408701 Versus Docetaxel in Previously Treated, Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Positive Metastatic Non-squamous Non-small-cell Lung Cancer Patients

Trajectories of Recovery After Intravenous Propofol Versus Inhaled VolatilE Anesthesia Trial

Vemurafenib in Children With Recurrent/Refractory BRAF Gene V600E (BRAFV600E)-Mutant Gliomas

A Study to Evaluate the Pharmacokinetics and Safety of INCB054707 in Participants With Normal Hepatic Function and Participants With Hepatic Impairment

Study of DKN-01 and Gemcitabine/Cisplatin in Patients With Carcinoma to Primary to the Intra- or Extra-Hepatic Biliary System or Gallbladder

Multicenter HomeVENT: Home Values and Experiences Navigation Track

Safety and Immunogenicity of V540B in Healthy Adults (V540B-002).

Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants With Relapsed or Refractory Advanced Non-Small Cell Lung Cancer With an FGFR Alteration

A Study in Adults and Adolescents With Angelman Syndrome (STARS)

A Prospective Cohort Post Market Registry Evaluating Outcomes of Bridge-Enhanced ACL Restoration (BEAR®)